Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

[New primary malignancies after breast cancer diagnosis: interplay of genetics, risk factors and treatment modalities].

Plavetić ND, Barić M, Solarić M, Vrbanec D.

Lijec Vjesn. 2013 Jan-Feb;135(1-2):27-33. Croatian.

PMID:
23607174
2.

Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk.

Fowble B, Hanlon A, Freedman G, Nicolaou N, Anderson P.

Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):679-90.

PMID:
11597809
4.

Second malignancies after breast cancer: the impact of different treatment modalities.

Kirova YM, De Rycke Y, Gambotti L, Pierga JY, Asselain B, Fourquet A; Institut Curie Breast Cancer Study Group..

Br J Cancer. 2008 Mar 11;98(5):870-4. doi: 10.1038/sj.bjc.6604241.

5.

Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.

Mauch PM, Kalish LA, Marcus KC, Coleman CN, Shulman LN, Krill E, Come S, Silver B, Canellos GP, Tarbell NJ.

Blood. 1996 May 1;87(9):3625-32.

6.

Nonbreast second malignancies after treatment of primary breast cancer.

Yadav BS, Sharma SC, Patel FD, Ghoshal S, Kapoor R, Kumar R.

Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1489-92. doi: 10.1016/j.ijrobp.2008.07.004.

PMID:
18804919
7.

Increased risk of second cancers following breast cancer: role of the initial treatment.

Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Lê MG.

Breast Cancer Res Treat. 2000 Jun;61(3):183-95.

PMID:
10965995
8.

Breast cancer risk in women with a primary ovarian cancer--a case-control study.

Bergfeldt K, Nilsson B, Einhorn S, Hall P.

Eur J Cancer. 2001 Nov;37(17):2229-34.

PMID:
11677112
9.

Risk of second primary cancer among women with breast cancer: a population-based study in Granada (Spain).

Molina-Montes E, Pollán M, Payer T, Molina E, Dávila-Arias C, Sánchez MJ.

Gynecol Oncol. 2013 Aug;130(2):340-5. doi: 10.1016/j.ygyno.2013.04.057.

PMID:
23648471
10.

Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.

Galper S, Gelman R, Recht A, Silver B, Kohli A, Wong JS, Van Buren T, Baldini EH, Harris JR.

Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):406-14.

PMID:
11872286
11.
12.

Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers.

Cook LS, Weiss NS, Schwartz SM, White E, McKnight B, Moore DE, Daling JR.

J Natl Cancer Inst. 1995 Sep 20;87(18):1359-64.

PMID:
7658496
13.

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group.

Rutqvist LE, Johansson H, Signomklao T, Johansson U, Fornander T, Wilking N.

J Natl Cancer Inst. 1995 May 3;87(9):645-51.

PMID:
7752269
15.

Lung cancer risk and radiation dose among women treated for breast cancer.

Inskip PD, Stovall M, Flannery JT.

J Natl Cancer Inst. 1994 Jul 6;86(13):983-8.

PMID:
8007020
17.

Breast masses in women treated for childhood cancer: incidence and screening guidelines.

Kaste SC, Hudson MM, Jones DJ, Fryrear R, Greenwald CA, Fleming ID, Pratt CB.

Cancer. 1998 Feb 15;82(4):784-92.

PMID:
9477113
18.

Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer.

Fornander T, Hellström AC, Moberger B.

J Natl Cancer Inst. 1993 Nov 17;85(22):1850-5.

PMID:
8230266
19.

Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer.

Bernstein JL, Thompson WD, Risch N, Holford TR.

Am J Epidemiol. 1992 Oct 15;136(8):925-36.

PMID:
1456269
20.

Health-related quality of life in early breast cancer.

Groenvold M.

Dan Med Bull. 2010 Sep;57(9):B4184.

PMID:
20816024

Supplemental Content

Support Center